Leukemia & Lymphoma Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.
Featured
In the third part of this roundtable, Steven Horwitz, MD; Alison Moskowitz, MD; and Barbara Pro, MD, discuss notable advancements in the standard treatment of T-cell lymphoma.
View More
In the second part of this roundtable, Steven Horwitz, MD; Alison Moskowitz, MD; and Barbara Pro, MD, discuss the background, findings, and importance of the ECHELON-2 clinical trial.
View More
In the first part of this roundtable, Steven Horwitz, MD; Alison Moskowitz, MD; and Barbara Pro, MD, discuss the challenges of treating patients with T-cell lymphoma.
View More
Paolo Caimi, MD, discusses findings from a study examining the use of prophylactic tocilizumab prior to anti-CD19 CAR-T therapy for relapsed/refractory lymphoma.
View More
Dr Bussel shares insight on hot topics, highlights, and key takeaways from this year's virtual event.
View More
Dr Percival discusses the provision of care to patients with AML during the COVID-19 pandemic.
View More
On this episode of Blood Bytes, John Leonard, MD, and Richard Furman, MD, discuss BTK inhibitors for the treatment of CLL and lymphomas.
View More
Mary-Elizabeth Percival, MD, outlines considerations for treating patients with hematologic malignancies during the COVID-19 pandemic.
View More
Mehdi Hamadani, MD, discusses the impact the global pandemic has had on bone marrow and stem cell transplantation for patients with blood cancers.
View More
Stay in the know.
OncNet Newsletter